동영상
-
Health Canada approves Moderna's new mRNA shots for flu, flu-COVID combo
-
Personalized mRNA vaccine lowers melanoma risk
-
Personalized mRNA vaccine lowers melanoma risk
-
Jobs Report Shocker Can't Stop a Wild Tech Comeback 🚨 | Stock Market Live
-
Cancer vaccine breakthrough: Melanoma mRNA treatment set to cut recurrence in world-first
-
CBC News: The National | Trump names Stephen Miller chief of staff
-
New trial shows cancer vaccine cuts risk of melanoma returning
-
The Big 3: PLTR, MRNA, DELL
-
Palantir's Parabolic Run and an Exclusive Pentagon F-35 Report | Stock Market Live
-
SpaceX Soars as OpenAI's Accounting Scandal Rattles Wall Street | Stock Market Live
블로그
-
모더나 주가 폭등 이끈 '맞춤형 암 백신', 상업적 대박으로 이어질까?
간단 브리핑 이 글은 Barron's의 "Moderna’s cancer vaccine gives stock a new growth story. 을 번역해 옮긴 것으로, 간단히 요약하면, 맞춤형 암 백신(인티스메란)의 3상 임상 성공 모더나와 머크가 공동 개발 중인 mRNA 기반 맞춤형 암 백신 '인티스메란'이 흑색종 환자
- 모더나 Moderna Stock Surges 177% on Personalized Cancer Vaccine "vaccine hero" during the COVID-19 pandemic for developing one of the world’s first messenger RNA (mRNA On August 19 (local time), Moderna’s stock price surged 176.97% to close at $174.38 on the New York Stock